To investigate the efficacy of troxerutin combined with argatroban on acute ischemic stroke (AIS) patients and its effects on serum levels of high sensitivity C-reactive protein (hs-CRP), matrix metalloproteinase-9 (MMP-9) and soluble CD40 ligand (sCD40L).
A total of 108 AIS patients admitted to our hospital from March 2019 to March 2022 were selected and randomly divided into control group and observation group by random number table method, with 54 patients in each group. The control group was treated with argatroban anticoagulant therapy, and the observation group was treated with troxerutin combined with argatroban, and the course of treatment was 7 days. The efficacy, cerebral blood flow (CBF), cerebral blood volume (CBV), neurological function, quality of life, serum hS-CRP, MMP-9 and sCD40L levels, the incidence of complications and adverse reactions were compared between the two groups.
Both groups successfully completed the treatment. The total effective rate of the observation group was higher than that of the control group (92.59% vs 75.93%, χ2=4.468, P<0.05). After treatment, the scores of National Institutes of Health stroke scale [(8.24±2.65) vs (10.21±3.12)] and modified Rankin scale score [(2.05±0.23) vs (3.21±0.71] in the observation group were lower than those in the control group (P<0.05). The Barthel index [(75.36±15.09) vs (69.20±13.48)], CBF [(72.51±21.35) mL/100 mg vs (62.42±19.35)mL/100 mg] and CBV [(95.36±25.66) mL/100 mg vs (83.20±22.48) mL/100 mg] in the observation group were higher than those in the control group (P<0.05). The levels of hS-CRP [(2.34±0.52)mg/L vs (4.02±1.09)mg/L], MMP-9[(3.02±0.64)μg/L vs (5.16±1.39)μg/L] and sCD40L [(150.29±20.92)pg/mL vs (196.35±35.12)pg/mL] in the observation group were lower than those in the control group (P<0.05).
Compared with argatroban alone, troxerutin combined with argatroban in the treatment of AIS can significantly reduce serum hS-CRP, MMP-9 and sCD40L levels, improve cerebral blood perfusion and neurological function, and improve quality of life.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |